Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1.39B
-
Number of holders
-
191
-
Total 13F shares, excl. options
-
48.7M
-
Shares change
-
+1.16M
-
Total reported value, excl. options
-
$6.03B
-
Value change
-
+$140M
-
Put/Call ratio
-
1.37
-
Number of buys
-
112
-
Number of sells
-
-69
-
Price
-
$123.95
Significant Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q2 2019
225 filings reported holding ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share as of Q2 2019.
BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) has 191 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.7M shares
of 1.39B outstanding shares and own 3.51% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (11.8M shares), FMR LLC (5.62M shares), HILLHOUSE CAPITAL ADVISORS, LTD. (4.44M shares), Capital International Investors (2.47M shares), WELLINGTON MANAGEMENT GROUP LLP (2.47M shares), Temasek Holdings (Private) Ltd (2.27M shares), BlackRock Inc. (2.01M shares), VANGUARD GROUP INC (1.24M shares), HILLHOUSE CAPITAL MANAGEMENT, LTD. (1.03M shares), and PRIMECAP MANAGEMENT CO/CA/ (929K shares).
This table shows the top 191 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.